Cargando…

Neuronal ER-Signalosome Proteins as Early Biomarkers in Prodromal Alzheimer's Disease Independent of Amyloid-β Production and Tau Phosphorylation

There exists considerable interest to unveil preclinical period and prodromal stages of Alzheimer's disease (AD). The mild cognitive impairment (MCI) is characterized by significant memory and/or other cognitive domains impairments, and is often considered the prodromal phase of AD. The cerebro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mesa-Herrera, Fátima, Marín, Raquel, Torrealba, Eduardo, Santos, Guido, Díaz, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119323/ https://www.ncbi.nlm.nih.gov/pubmed/35600079 http://dx.doi.org/10.3389/fnmol.2022.879146

Ejemplares similares

In-Out-Test: A New Paradigm for Sorting the Wheat from the Chaff in Prodromal Alzheimer’s Disease
por: Torrealba, Eduardo, et al.
Publicado: (2019)

Amyloid imaging in prodromal Alzheimer's disease
por: Ossenkoppele, Rik, et al.
Publicado: (2011)

Signalosomes in the Brain: Relevance in the Development of Certain Neuropathologies Such as Alzheimer's Disease
por: Marin, Raquel
Publicado: (2011)

Comprehensive Characterization of CK1δ-Mediated Tau Phosphorylation in Alzheimer’s Disease
por: Roth, Aileen, et al.
Publicado: (2022)

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
por: den Haan, Jurre, et al.
Publicado: (2018)

Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients
por: Saint-Aubert, Laure, et al.
Publicado: (2013)

Evaluation of choroidal thickness in prodromal Alzheimer’s disease defined by amyloid PET
por: López-de-Eguileta, Alicia, et al.
Publicado: (2020)

Memory concerns in the early Alzheimer's disease prodrome: Regional association with tau deposition
por: Swinford, Cecily G., et al.
Publicado: (2018)

Sleep and Tau Pathology in Vietnam War Veterans with Preclinical and Prodromal Alzheimer’s Disease
por: Andrews, Murray, et al.
Publicado: (2021)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
por: Reddy, P. Hemachandra, et al.
Publicado: (2019)

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Shen, Xue-Ning, et al.
Publicado: (2021)

Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET
por: López-de-Eguileta, Alicia, et al.
Publicado: (2019)

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2023)

Disruption of DYRK1A-induced hyperphosphorylation of amyloid-beta and tau protein in Alzheimer’s disease: An integrative molecular modeling approach
por: Shukla, Rohit, et al.
Publicado: (2023)

Prediction of tau accumulation in prodromal Alzheimer’s disease using an ensemble machine learning approach
por: Kim, Jaeho, et al.
Publicado: (2021)

Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease
por: Janelidze, Shorena, et al.
Publicado: (2022)

Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer’s disease
por: An, Seong Soo A., et al.
Publicado: (2023)

Human tau increases amyloid β plaque size but not amyloid β‐mediated synapse loss in a novel mouse model of Alzheimer's disease
por: Jackson, Rosemary J., et al.
Publicado: (2016)

Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation
por: Satpathy, Shankha, et al.
Publicado: (2015)

Brainstem tau pathology in Alzheimer’s disease is characterized by increase of three repeat tau and independent of amyloid β
por: Uematsu, Miho, et al.
Publicado: (2018)

Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer’s Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein
por: Young, Jessica E., et al.
Publicado: (2018)

TRPC3 Channel Activity and Viability of Purkinje Neurons can be Regulated by a Local Signalosome
por: Aslam, Naveed, et al.
Publicado: (2022)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
por: Pai, Ming-Chyi, et al.
Publicado: (2021)

APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer’s Disease
por: Hohman, Timothy J., et al.
Publicado: (2017)

The Effect of 40-Hz Light Therapy on Amyloid Load in Patients with Prodromal and Clinical Alzheimer's Disease
por: Ismail, Rola, et al.
Publicado: (2018)

Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease
por: Pfeil, Julia, et al.
Publicado: (2021)

Optimized Turmeric Extract Reduces β-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer’s Transgenic Mice
por: Douglas Shytle, R, et al.
Publicado: (2012)

Mechanical Dilution of Beta-amyloid Peptide and Phosphorylated Tau Protein in Alzheimer's Disease: Too Simple to be True?
por: Menéndez González, Manuel
Publicado: (2017)

Inflammaging as a prodrome to Alzheimer's disease
por: Giunta, Brian, et al.
Publicado: (2008)

β-Amyloid–Dependent and –Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease
por: Kumar, Atul, et al.
Publicado: (2022)

An acetylation–phosphorylation switch that regulates tau aggregation propensity and function
por: Carlomagno, Yari, et al.
Publicado: (2017)

Association of the Polygenic Risk Score With the Probability of Prodromal Parkinson’s Disease in Older Adults
por: Maraki, Maria I., et al.
Publicado: (2021)

Retraction: An aberrant phosphorylation of amyloid precursor protein tyrosine regulates its trafficking and the binding to the clathrin endocytic complex in neural stem cells of Alzheimer's disease patients
Publicado: (2023)

Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia
por: Therriault, Joseph, et al.
Publicado: (2021)

Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
por: Horie, Kanta, et al.
Publicado: (2020)

Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease
por: Yu, Chao-Chao, et al.
Publicado: (2019)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

Retraction: Different Amyloid-β Self-Assemblies Have Distinct Effects on Intracellular Tau Aggregation
Publicado: (2021)

Deleterious and protective effects of epothilone-D alone and in the context of amyloid β- and tau-induced alterations
por: Robles-Gómez, Ángel Abdiel, et al.
Publicado: (2023)

New Treatment for Alzheimer's Disease, Kamikihito, Reverses Amyloid-β-Induced Progression of Tau Phosphorylation and Axonal Atrophy
por: Watari, Hidetoshi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rbu41pv7hchmga33a377cf1daa